Antiproliferative effect of rapamycin on growth factor-stimulated human adult lung fibroblasts in vitro may explain its superior efficacy for prevention and treatment of allograft obliterative airway disease in vivo

Transplant Proc. 1997 Feb-Mar;29(1-2):614-5. doi: 10.1016/s0041-1345(96)00325-9.
No abstract available

MeSH terms

  • Adult
  • Bronchiolitis Obliterans / drug therapy
  • Bronchiolitis Obliterans / prevention & control*
  • Cell Division / drug effects
  • Cell Line
  • DNA / biosynthesis
  • Fibroblasts
  • Graft Rejection / drug therapy
  • Graft Rejection / prevention & control*
  • Growth Substances / pharmacology*
  • Heart-Lung Transplantation / immunology
  • Heart-Lung Transplantation / pathology
  • Heart-Lung Transplantation / physiology
  • Humans
  • Immunosuppressive Agents / pharmacology*
  • Lung / cytology*
  • Lung / drug effects
  • Lung Transplantation / immunology
  • Lung Transplantation / pathology
  • Lung Transplantation / physiology*
  • Polyenes / pharmacology*
  • Sirolimus
  • Transplantation, Homologous

Substances

  • Growth Substances
  • Immunosuppressive Agents
  • Polyenes
  • DNA
  • Sirolimus